Related Experiment Video
Updated: Nov 24, 2025

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
Published on: November 1, 2019
Binding Interactions of Peptide Aptamers
Roger R C New1,2, Tam T T Bui3, Michal Bogus1
1Vaxcine (UK) Limited, London Bioscience Innovation Centre, London NW1 0NH, UK.
Abstract:
Peptide aptamers are short amino acid chains that are capable of binding specifically to ligands in the same way as their much larger counterparts, antibodies. Ligands of therapeutic interest that can be targeted are other peptide chains or loops located on the surface of protein receptors (e.g., GCPR), which take part in cell-to-cell communications either directly or via the intermediary of hormones or signalling molecules. To confer on aptamers the same sort of conformational rigidity that characterises an antibody binding site, aptamers are often constructed in the form of cyclic peptides, on the assumption that this will encourage stronger binding interactions than would occur if the aptamers were simply linear chains. However, no formal studies have been conducted to confirm the hypothesis that linear peptides will engage in stronger binding interactions with cyclic peptides than with other linear peptides. In this study, the interaction of a model cyclic decamer with a series of linear peptide constructs was compared with that of a linear peptide with the same sequence, showing that the cyclic configuration does confer benefits by increasing the strength of binding.
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Peptide Bonds
Protein-protein Interfaces
Ligand Binding and Linkage
The Equilibrium Binding Constant and Binding Strength
Drug-Receptor Bonds
In...

